BPC-157 is a synthetic pentadecapeptide — 15 amino acids — derived from the gastric juice protein BPC. Its sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) is stable enough to survive some gastric acid exposure, which made it interesting to Sikiric's group at the University of Zagreb as far back as the early 1990s. The cumulative body of pre-clinical research — culminating in Sikiric et al.'s 2018 review and the earlier 2011 J Physiol Pharmacol mechanistic paper — documents effects on angiogenesis, nitric oxide pathway upregulation, collagen IV synthesis, and cytoprotective activity across multiple tissue systems. All of that research was conducted with precisely prepared solutions.
This is the point investigators in the UAE often underestimate: a vial of BPC-157 is lyophilized (freeze-dried) powder, not a ready-to-use solution. Until you add bacteriostatic water and do the arithmetic correctly, you cannot draw a meaningful dose. Get the concentration wrong and every subsequent data point in your research log is off — not slightly, but by a factor of two or three if you chose a different BAC water volume than you calculated for. REVIVE LAB UAE supplies HPLC-verified, lot-COA, cold-chain dispatched BPC-157 5 mg vials precisely because the starting material needs to be correct before any reconstitution math can be trusted.
Rushing reconstitution without the right kit is how vials get wasted. Confirm you have the following before touching the vial:
BAC water is the correct diluent — not sterile water for injection, not saline. The benzyl alcohol preservative (0.9% by volume) suppresses microbial growth across the multi-day research window. Using plain sterile water shortens the safe research use window dramatically and introduces contamination risk in a multi-draw vial context.
Every number below follows from one identity: concentration (mcg/mL) = total peptide mass (mcg) ÷ total volume (mL). A 5 mg vial contains 5,000 mcg. The volume of BAC water you add determines the rest.
| BAC Water Added | Total Volume | Concentration | 1 IU on U-100 Syringe | 10 IU on U-100 Syringe |
|---|---|---|---|---|
| 1 mL | ~1 mL | 5,000 mcg/mL (5 mg/mL) | 50 mcg | 500 mcg |
| 2 mL | ~2 mL | 2,500 mcg/mL (2.5 mg/mL) | 25 mcg | 250 mcg |
| 2.5 mL | ~2.5 mL | 2,000 mcg/mL (2 mg/mL) | 20 mcg | 200 mcg |
| 5 mL | ~5 mL | 1,000 mcg/mL (1 mg/mL) | 10 mcg | 100 mcg |
For the research-context 250-500 mcg/day range cited in Sikiric et al. (2011, 2018), the two most practical options from REVIVE LAB UAE's 5 mg vials are:
The 2 mL option is generally preferred by investigators because larger syringe volumes reduce relative draw error. At 2.5 mg/mL, a 1 IU misread on the syringe introduces only 25 mcg error — a 5% variance on a 500 mcg target, rather than 10% at double concentration.
A U-100 syringe holds 100 units in 1 mL — so 1 IU = 0.01 mL = 10 microlitres. The "units" markings are just a volumetric scale; they have nothing to do with insulin when used for peptide reconstitution. Keep that firmly in mind. At 2.5 mg/mL:
| Syringe Marking (IU) | Volume (mL) | BPC-157 Dose (mcg) at 2.5 mg/mL |
|---|---|---|
| 5 IU | 0.05 mL | 125 mcg |
| 10 IU | 0.10 mL | 250 mcg |
| 20 IU | 0.20 mL | 500 mcg |
| 40 IU | 0.40 mL | 1,000 mcg |
Consistent technique protects both the peptide and the sterility of the vial across multiple draws over the research window.
The pre-clinical literature and peptide stability data converge on a 28-day research use window for reconstituted BPC-157 with BAC water at 2-8°C. This is materially longer than peptides reconstituted with plain sterile water (typically 5-7 days), which is why BAC water is the standard diluent for multi-draw vials. Lyophilized (unreconstituted) vials, stored correctly at 2-8°C in the original sealed carton, carry a significantly longer shelf life — REVIVE LAB UAE vials are lot-dated and tested accordingly.
| State | Storage Condition | Research Use Window | Notes |
|---|---|---|---|
| Lyophilized (sealed) | 2-8°C, dark | Per lot expiry (typically 12-24 months) | Most stable state; do not freeze |
| Lyophilized (sealed) | -20°C, dark | Extended (years) | Freeze only if long-term archiving |
| Reconstituted with BAC water | 2-8°C, dark | Up to 28 days | Label vial with date; discard if cloudy |
| Reconstituted with sterile water | 2-8°C, dark | 5-7 days | Not recommended for multi-draw use |
| Reconstituted, room temperature | 22-25°C | Hours only | Significant degradation risk |
One practical implication for investigators in the UAE: Dubai summer ambient temperatures exceed 40°C outdoors. A reconstituted vial left on a bench for even 30 minutes during transit between a lab and a fridge can degrade meaningfully. Always transport reconstituted BPC-157 in an insulated pouch with a gel pack — the same cold-chain discipline REVIVE LAB UAE applies to its courier dispatches.
Most BPC-157 research failures are not molecule failures — they are preparation failures. Here are the four most common errors seen among investigators who buy BPC-157 UAE for the first time:
BPC-157 has an unusually broad pre-clinical research footprint. Sikiric and colleagues at the University of Zagreb have been its primary investigators across three decades, with the Journal of Physiology and Pharmacology 2011 paper ("Pentadecapeptide BPC 157") providing the mechanistic framework: upregulation of the nitric oxide (NO) pathway, induction of VEGF and angiogenesis, and cytoprotective effects on gastric and intestinal mucosa. The 2018 cumulative review extended this across musculoskeletal, CNS, and vascular tissue models.
The dose ranges cited across this body of pre-clinical work are predominantly 250-500 mcg/day in the systemic research models — a range that maps neatly to the 2 mL BAC water reconstitution of a 5 mg vial described above. This is not coincidental: the 250 mcg lower bound (10 IU at 2.5 mg/mL) and 500 mcg upper bound (20 IU at 2.5 mg/mL) fall squarely in the middle of the U-100 syringe's readable range, where measurement precision is highest. The investigators who designed these dose ranges were working with well-reconstituted, precisely measured solutions — and that precision starts with correct BAC water volumes.
It bears emphasising: everything in this post refers to pre-clinical research. BPC-157 is not an approved therapeutic in any jurisdiction and this content does not constitute medical advice or a protocol for human use.
REVIVE LAB UAE supplies HPLC-verified, lot-COA, cold-chain dispatched BPC-157 5 mg vials across all 7 emirates. Whether you are based in Dubai Marina, JBR, Business Bay, JVC, DIFC, Downtown, Jumeirah, Palm Jumeirah, Emirates Hills or Arabian Ranches — same-day dispatch applies for orders placed before the daily cut-off. All shipments leave in insulated cold-chain packaging verified to hold 2-8°C through UAE summer transits. Cash on delivery is available UAE-wide; USDT crypto pay (TRC20) is also accepted at a 5% pre-pay discount for researchers who prefer that route.
| Emirate / City | Delivery Window | Cash on Delivery | Cold-Chain Packaging |
|---|---|---|---|
| Dubai (Marina, JBR, Business Bay, JVC, DIFC, Downtown, Palm, Jumeirah) | Same-day, 4-8 hours | Yes | Yes |
| Abu Dhabi (Corniche, Yas Island, Saadiyat, Reem) | Next-day, 18-24 hours | Yes | Yes |
| Sharjah | Same-day / next-day, 8-18 hours | Yes | Yes |
| Ajman | Next-day, 18-24 hours | Yes | Yes |
| Ras Al Khaimah (RAK) | Next-day, 18-24 hours | Yes | Yes |
| Fujairah | Next-day, 24 hours | Yes | Yes |
| Umm Al Quwain (UAQ) | Next-day, 18-24 hours | Yes | Yes |
| Al Ain | Next-day, 24 hours | Yes | Yes |
A researcher in Business Bay who orders bpc-157 same day Dubai before 2pm can typically have cold-packed 5 mg vials in hand by evening — already in optimal condition for reconstitution that same session. This is the operational difference between a genuine UAE-based peptides supplier and an offshore drop-shipper who adds "UAE" to a product title. REVIVE LAB UAE stocks bpc-157 in stock UAE year-round; there is no pre-order waitlist, no estimated restock, no shipping from a freezer farm in Eastern Europe.
REVIVE LAB UAE is Dubai-based, not a UAE-registered shell fronting an overseas operation. Every batch of BPC-157 is HPLC-tested to confirm peptide identity and purity, with lot-specific COAs available on request. Cold-chain dispatch is the default, not an upsell: vials leave in validated insulated packaging and arrive in research-grade condition whether the delivery is in Dubai Marina or Fujairah. For investigators who want to verify what they are working with before reconstitution — rather than reconstituting first and wondering later — the COA is the starting point, and REVIVE LAB UAE provides it on every order.
The broader REVIVE LAB UAE research catalogue includes Retatrutide, Tesamorelin, GHK-Cu, TB-500, Semax, MOTS-c and NAD+ — the same cold-chain and HPLC-verification standards apply across all molecules. For BPC-157 specifically, the only stocked vial size is 5 mg, which is the unit most pre-clinical research protocols reference. This avoids the confusion that arises when suppliers offer multiple strengths with different reconstitution instructions; here the math is fixed, the COA is attached, and the supply is UAE-local.
Draw your calculated volume of BAC water into a clean syringe and inject it slowly down the inner wall of the BPC-157 vial — never directly onto the lyophilized cake. For a 2 mL reconstitution (yielding 2,500 mcg/mL), 10 IU on a U-100 syringe equals exactly 250 mcg. For a 1 mL reconstitution (5,000 mcg/mL), 10 IU equals 500 mcg. Swirl gently to dissolve — do not shake or vortex. Label the vial with the date and refrigerate immediately at 2-8°C. The research use window with BAC water is up to 28 days.
REVIVE LAB UAE supplies HPLC-verified, lot-COA BPC-157 5 mg vials with cold-chain dispatch across all 7 emirates. Same-day delivery operates within Dubai for orders placed before the daily cut-off — typically 4-8 hours to Dubai Marina, JBR, Business Bay, JVC, DIFC, Downtown, Jumeirah and Palm Jumeirah. Abu Dhabi, Sharjah, Ajman, RAK, Fujairah and UAQ receive next-day 24h delivery. Cash on delivery and USDT crypto pay are both accepted. For bpc-157 Dubai 24h delivery, REVIVE LAB UAE is the in-stock, UAE-based option.
The peer-reviewed pre-clinical literature — principally Sikiric et al. 2011 (J Physiol Pharmacol) and the comprehensive 2018 review — references systemic research-context dose ranges of 250-500 mcg/day in animal models. At a 2 mL reconstitution of a 5 mg vial (2,500 mcg/mL), these map to 10 IU (250 mcg) and 20 IU (500 mcg) on a U-100 insulin syringe respectively — clean, readable draws. These figures are cited for research reference only; they do not constitute medical advice or a protocol for human use.